In this Book
- Clinical Trials in Ovarian Cancer
- Published by: Rutgers University Press
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
When a patient is diagnosed with a gynecological malignancy, she and her doctors must make urgent, high-risk decisions about her course of treatment. In selecting an appropriate plan of care, physicians must weigh the patient’s individual needs, the tumor’s specific characteristics, and the treatment’s potential side effects. Because there is no one-size-fits-all treatment solution, a plethora of clinical trials have been performed on ovarian cancer patients, but clinicians may struggle to keep up with this ever-growing body of research.
Collecting and synthesizing research findings from a wide array of medical journal articles and book chapters, Clinical Trials in Ovarian Cancer provides physicians with an invaluable resource. Gynecologic oncologist Christine S. Walsh systematically outlines each of the seminal Phase III trials that have shaped the treatment of ovarian cancers, detailing the rationale for the trial, the patient population studied, treatment delivery methods, efficacy, toxicity, and trial conclusions. She provides a clear overview of established treatments, as well as still-controversial experimental approaches.
The first book to organize this cutting-edge research into an easy-to-use reference, Clinical Trials in Ovarian Cancer should help medical personnel at all levels provide their patients with the highest standard of care.
Table of Contents
- pp. vii-viii
- List of Tables
- pp. ix-x
- Preface and Acknowledgments
- pp. xi-xii
- 1. Early Stage Epithelial Ovarian Cancer
- pp. 13-57
- 5. Recurrent Epithelial Ovarian Cancer
- pp. 212-274
- pp. 275-278
- pp. 279-306
- pp. 307-334
- About the Author
- pp. 335-336
Launched on MUSE